Curaderm-BEC5 cream is a new topical treatment whose cosmetic outcome is far superior to current treatment methods.
| Conventional Methods - surgery,
radiotherapy and dermatological |
Curaderm-BEC5 |
| Formation of scar tissue. This is a life long consequence of skin cancer treatment | New skin growth to replace cancer cells with no scaring |
| Loss of skin tissue leaving unsightly gaps | Normal skin regrowth |
| A high rate of recurrence of the skin cancer | Curaderm-BEC5 medical research has proven that the skin cancer cannot recur. |
| Expensive - People wait weeks for that five minute visit with the doctor to get skin lesions removed, and at $250 and up per procedure. | A bottle of Curaderm-BEV5 that provides enough cream to treat which is enough to treat one or two large skin cancers, six average ones or a dozen sunspots for only US$115. |
Curaderm-BEC5 can get rid of the lesion with no evidence of scarring and in the very rare instances in which the lesion returns a simple reapplication of the cream will solve the problem.
Curaderm-BEC5 Cream has Achieved Outstanding Clinical Success for over 20 years.
Curaderm cream is a Clinically Proven Cream treatment whose cosmetic outcome is far superior to current treatment methods. People around the world are now turning to Curaderm-BEC5 as their preferred choice to DESTROY FOREVER non melanoma Skin Cancers deep below the skin
The Pharmaceutical Grade Active Ingredient, BEC, is a Major Medical Breakthrough as it does not burn or kill all human cells but selects and eliminates ONLY the Cancer Cells. Healthy Cells are UNTOUCHED.
Curaderm-BEC5 is a SKIN FRIENDLY treatment, NO Cuts, NO Burns or freezing, NO side Effects, NO expensive reconstructive surgery required. Your skin is not affected. Laboratory Biopsies and over 50,000 people have Confirmed that Curaderm-BEC Works.
Dermatologists from TEN United Kingdom Skin Cancer Treatment centre Hospitals have supported Curaderm-BEC5 curative claims. Dr. Sangeeta Punjab of the Royal London Hospital concluded Curaderm-BEC clinical evaluation by stating, “We consider that this rate of treatment success more than justifies the physician considering BEC as an alternative to currently predominant treatment such as surgical excision or cryotherapy.”
Read for yourself a scanned copy of the Clinical Evaluation of Curaderm-BEC released by 10 Skin Cancer Clinic hospitals.
